
BioSig Technologies Inc BSGM.OQ BSGM.O is expected to show a fall in quarterly revenue when it reports results on May 19 (estimated) for the period ending March 31 2025
LSEG's mean analyst estimate for BioSig Technologies Inc is for a loss of 5 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for BioSig Technologies Inc is $2.50, below its last closing price of $2.55.
This summary was machine generated May 16 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)